Results are presented for a QSAR analysis of bisamidines, using a similarity index as descriptor. The method allows for differences in conformation of bisamidines at the receptor site to be taken into consideration. In particular, it has been suggested by others that pentamidine binds in the minor groove of DNA in a so-called isohelical conformation, and our QSAR supports this suggestion. The molecular similarity index for comparison of molecules can be used as a parameter for correlating and hence rationalising the activity as well as suggesting the design of bioactive molecules. The studied compounds had been evaluated for potency against Leishmania mexicana amazonensis, and this potency was used as a dependent variable in a series of QSA...
<div><p>Recent technological breakthroughs in medicinal chemistry arena had ameliorated the perspect...
In an effort to develop a quantitative ligand-binding model for the receptor tyrosine kinases, a pha...
In an effort to develop a quantitative ligand-binding model for the receptor tyrosine kinases, a pha...
A relevant aspect in quantitative structure-activity (QSAR) and structure-selectivity (QSSR) relatio...
Aromatic bisamidines are active against Leishmania sp. and Pneumocystis carinii. The mode of action ...
A proposed model for the interaction of bisamidine analogues with the B-DNA receptor is established ...
In this paper we study different similarity based approaches for the development of QSAR model devot...
Abstract Two dynamic techniques recently developed to account for conformational flexibility of chem...
We used a new descriptor called the Klopman index in our software of the molecular comparative elect...
Chemical similarity between molecules, is a key concept in drug design and drug discovery. The advan...
Comparative molecular similarity indices analysis (CoMSIA) has been applied to a data set of cinnama...
A set of pyrimidine derivatives, tyrosine kinase inhibitors were investigated by using flexible atom...
The present study describes the implementation of a new three-dimensional quantitative structure-act...
Abstract Structure–activity relationship modelling is frequently used in the early stage of drug dis...
The present study describes the implementation of a new three-dimensional quantitative structure-act...
<div><p>Recent technological breakthroughs in medicinal chemistry arena had ameliorated the perspect...
In an effort to develop a quantitative ligand-binding model for the receptor tyrosine kinases, a pha...
In an effort to develop a quantitative ligand-binding model for the receptor tyrosine kinases, a pha...
A relevant aspect in quantitative structure-activity (QSAR) and structure-selectivity (QSSR) relatio...
Aromatic bisamidines are active against Leishmania sp. and Pneumocystis carinii. The mode of action ...
A proposed model for the interaction of bisamidine analogues with the B-DNA receptor is established ...
In this paper we study different similarity based approaches for the development of QSAR model devot...
Abstract Two dynamic techniques recently developed to account for conformational flexibility of chem...
We used a new descriptor called the Klopman index in our software of the molecular comparative elect...
Chemical similarity between molecules, is a key concept in drug design and drug discovery. The advan...
Comparative molecular similarity indices analysis (CoMSIA) has been applied to a data set of cinnama...
A set of pyrimidine derivatives, tyrosine kinase inhibitors were investigated by using flexible atom...
The present study describes the implementation of a new three-dimensional quantitative structure-act...
Abstract Structure–activity relationship modelling is frequently used in the early stage of drug dis...
The present study describes the implementation of a new three-dimensional quantitative structure-act...
<div><p>Recent technological breakthroughs in medicinal chemistry arena had ameliorated the perspect...
In an effort to develop a quantitative ligand-binding model for the receptor tyrosine kinases, a pha...
In an effort to develop a quantitative ligand-binding model for the receptor tyrosine kinases, a pha...